We are live on ! Find out more
SXTP icon

60 Degrees Pharmaceuticals
SXTP

7 hedge funds and large institutions have $22.5K invested in 60 Degrees Pharmaceuticals in 2025 Q4 according to their latest regulatory filings, with 2 funds opening new positions, 1 increasing their positions, 0 reducing their positions, and 2 closing their positions.

New
Increased
Maintained
Reduced
Closed

0.01% more ownership

Funds ownership: 1.04% → 1.05% (+0.01%)

0% more funds holding

Funds holding: 7 → 7 (0)

0% more first-time investments, than exits

New positions opened: 2 | Existing positions closed: 2

64% less capital invested

Capital invested by funds: $62.9K → $22.5K (-$40.4K)

Holders
7
Holders Change
–
Holders Change %
0%
% of All Funds
0.08%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
2
Increased
1
Reduced
–
Closed
2
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
Jane Street
Jane Street
New York
+$25.5K
2
TRCT
Tower Research Capital (TRC)
New York
+$4.17K
3
Barclays
Barclays
United Kingdom
+$1.75K

Top Sellers

Rank Fund Capital Flow
1
DS
DRW Securities
Illinois
-$37.3K
2
Citigroup
Citigroup
New York
-$278

SXTP Hedge Fund Activity: Q4 2025 in Review

7 of the 8,281 institutional investors tracked by Wall St. Rank reported a position in 60 Degrees Pharmaceuticals (SXTP) for Q4 2025, worth a combined $22.5K — down 64% from $62.9K a quarter earlier.

Fund positioning in SXTP was balanced in Q4 2025: 2 funds opened new positions, 2 closed out, 1 added to existing stakes and 0 trimmed.

The largest buyer was Jane Street, opening a new position worth an estimated $25.5K. The largest seller was DRW Securities, exiting entirely with an estimated $37.3K sold.

  • 7 institutional investors held 60 Degrees Pharmaceuticals (SXTP) as of Q4 2025, unchanged from Q3 2025.
  • Funds reported $22.5K of 60 Degrees Pharmaceuticals stock for Q4 2025, down 64% quarter-over-quarter.
  • 2 funds opened new 60 Degrees Pharmaceuticals positions in Q4 2025 and 2 closed out, a net change of 0 holders.
  • The largest 60 Degrees Pharmaceuticals buyer in Q4 2025 was Jane Street, an estimated $25.5K added.
  • The largest 60 Degrees Pharmaceuticals seller in Q4 2025 was DRW Securities, an estimated $37.3K sold.

Based on aggregated 13F filings for Q4 2025.